News articles

News article list

• NICE recommends offering PrEP to people at high risk of HIV for first time

  People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the first time.

• NICE recommends first treatment for rare blood disorder

  People with a rare blood disorder have access to a new treatment following draft guidance from NICE.

• NICE recommends several treatment options to help with rheumatoid arthritis

  Around 25,000 people with moderate rheumatoid arthritis that has not responded to conventional therapies are set to benefit from the recommendations announced today.

• Risdiplam not recommend for treating spinal muscular atrophy

  NICE has today (2 June 2021) published draft guidance for which does not recommend risdiplam for treating the rare genetic disorder spinal muscular atrophy (SMA).

• Women should be offered induced labour earlier than previously advised

  Induced labour should be offered earlier than previously advised to make birth safer for women and their babies, according to draft guidelines published by NICE today (25 May 2021). The updated recommendations strengthen previous advice in the light of new evidence on induction timings.

• Patients with rare blood disorders to receive new treatment option, says NICE

  In final guidance published today (20 May 2021), NICE has recommended ravulizumab (Ultomiris, Alexion Pharmaceuticals) as a treatment for paroxysmal nocturnal haemoglobinuria (PNH). Draft guidance published 19 May 2021 also recommends the treatment for atypical haemolytic uraemic syndrome (aHUS).